Ground Swell Capital’s Xtant Medical Holdings XTNT Stock Holding History

Ground Swell Capital’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.5K	Buy	+13,070	New	+$6.28K	0.01%	131

Other funds holding XTNT

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ground Swell Capital's XTNT Position: Q2 2026 in Review

Ground Swell Capital opened a new position in Xtant Medical Holdings (XTNT) in Q2 2026: 13,070 shares worth $5.5K. The stake represents 0.01% of the portfolio and ranks #131 among its holdings.

32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

Ground Swell Capital held 13,070 shares of Xtant Medical Holdings worth $5.5K as of Q2 2026.
Xtant Medical Holdings was a new Ground Swell Capital position in Q2 2026.
Xtant Medical Holdings made up 0.01% of Ground Swell Capital's portfolio in Q2 2026, its #131 holding.
32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Ground Swell Capital's 13F filing for Q2 2026, filed 5 Aug 2026.